v.) and oral administration both at 5 mg/kg, were
determined before and after enzymatic hydrolysis with beta-glucuronidase/sulphatase, respectively, by a HPLC-UV method. The results showed that free ICT plasma concentration after i.v. dose was rapidly decreased with average t(1/2,) (lambda) of 0.43 h, while the total ICT concentration was decreased slowly with t(1/2,) (lambda) of 6.86 h. The area under the curve of ICT conjugated metabolites was about 11-fold higher than that of free ICT. The majority of ICT in the body was excreted from the bile with 68.05% of dose over 8h after iv. dosing, in which only 0.15% was in parent form. While very little amount of ICT was excreted from the urine with 3.01% of dose over 24h, in which the parent form was 0.62%. After oral administration, very little amount of parent ICT was detected click here only
in 0.5, 1 or 2 h plasma samples with the concentration less than LOQ however, its total plasma concentration after enzymatic hydrolysis treatment was at relative high level with average maximum concentration of 0.49 mu g/ml achieved at 1 h post dose. The oral bioavailability of ICT was NCT-501 order 35% of dose, estimated by its total plasma drug concentrations. It is concluded that ICT can be easily absorbed into the body, and then rapidly conversed to its conjugated metabolites, and finally removed from the body mainly by biliary excretion. (C) 2012 Elsevier GmbH. All rights reserved.”
“For the first time cellular uptake studies of cisplatin were addressed by elemental speciation analysis at biological relevant concentration levels, i.e. drug exposure concentration ranging at 5 mu M. The quantification of intact, free cisplatin AZD4547 clinical trial in cell models was investigated by two complementary LC-ICP-MS methods, using chromatographic separations based on pentafluorophenylpropyl
siloxane bonded stationary phases (Discovery HS F5) and on porous graphitized carbon (Hypercarb). Limits of detection for cisplatin were 0.013 and 0.11 mu g L(-1) (given as total drug), respectively. Cisplatin-once entering the cancer cell-is known to undergo reactions with proteins and peptides in the cytosol by forming adducts. Hence, due to the limited selectivity of one-dimensional LC separation, efficient protein removal was a prerequisite for accurate quantification in such complex biological matrix as cell lysate. Centrifugal filtration (cut-off of 10 kDa) was the method of choice. Exposure of two different cell models to 5 mu M cisplatin for 24 hours resulted in cisplatin concentration levels ranging between 0.2 and 1.5 mu g g(-1) protein. Despite the poor recovery of the columns regarding total Pt in filtrated samples, the accuracy of cisplatin quantification was given, which was shown via species specific IDMS and standard addition.